Cryosafe CryoMizer Liquid Nitrogen Storage Tank

Overview

The Cryosafe CryoMizer series represents a purpose-engineered line of static liquid nitrogen (LN₂) storage tanks designed for long-term, ultra-low-temperature preservation of biological specimens—including stem cells, primary tissues, oocytes, embryos, PBMCs, and genomic samples. Utilizing high-efficiency vacuum-insulated double-walled stainless steel construction, the CryoMizer operates in two distinct thermal modes: vapor-phase storage (stable at −135 °C, minimizing cross-contamination risk) and liquid-phase immersion (−196 °C, optimal for maximal cryoprotectant efficacy). Each model is validated for sustained thermal stability under routine laboratory conditions, with optimized neck tube geometry and multi-layer superinsulation to suppress boil-off and extend hold time between refills. The system’s architecture prioritizes sample integrity, operator safety, and audit readiness—making it suitable for ISO 20387-accredited biobanks, clinical trial specimen repositories, and academic core facilities requiring traceable, reproducible cryostorage.

Key Features

• Vacuum-jacketed stainless steel vessel with helium-leak-tested integrity and <0.001 Pa residual pressure for minimized heat ingress
• Dual-mode operation: programmable vapor-phase temperature control (−135 °C ± 3 °C) and direct liquid-phase immersion (−196 °C)
• Modular rack system with standardized 2 mL cryovial compatibility; racks engineered for vertical load distribution and frost-resistant polymer guides
• Integrated castor-mounted base with locking swivel casters (load-rated to 200 kg) enabling safe repositioning without lifting
• Calibrated LN₂ level gauge with dual-scale readout (volume in liters and estimated days-to-empty based on nominal evaporation rate)
• Neck tube diameter optimized for minimal thermal bridging: 127 mm (CM-1) to 216 mm (CM-2–CM-4), supporting robotic arm access where integrated automation is deployed
• Surface-finished exterior (Ra ≤ 0.8 µm) compatible with routine decontamination using ethanol, hydrogen peroxide vapor, or quaternary ammonium agents

Sample Compatibility & Compliance

The CryoMizer accommodates standard ANSI/SLAS-format cryoboxes (plastic or paper), 2 mL external-thread cryovials (Nunc, Corning, Thermo Fisher), and custom-fit aluminum or polypropylene racks. All models comply with IEC 61000-6-3 (EMC emissions) and UL 1278 (portable electric equipment) safety standards. While not FDA-cleared as a medical device, the tank meets essential requirements referenced in FDA Guidance for Industry: Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps), including physical separation of vapor/liquid zones and documentation-ready configuration control. Optional accessories—including CE-marked liquid-level alarm modules and 21 CFR Part 11–compliant data loggers—support validation under GCP, GLP, and GMP frameworks.

Software & Data Management

The CryoMizer is a standalone hardware platform requiring no embedded firmware or proprietary software. However, its mechanical design enables seamless integration with third-party environmental monitoring systems (e.g., Sensaphone, DicksonOne, or Vaisala viewLinc) via analog 4–20 mA output (when paired with optional LN₂ level transmitter) or digital RS-485 Modbus RTU interface. Sample tracking is managed externally through LIMS platforms; rack positions are labeled with laser-etched alphanumeric identifiers (A01–Z99) compatible with barcode scanning workflows. Audit trails for LN₂ refills, temperature excursions, and maintenance events are maintained manually or via connected IoT gateways—fully aligning with ALCOA+ data integrity principles.

Applications

• Long-term archival storage of human biospecimens in biorepositories accredited to ISO 20387:2018
• Cryopreservation of induced pluripotent stem cell (iPSC) lines under cGMP-compliant conditions
• Storage of clinical-grade CAR-T cell products prior to infusion
• Backup storage for national genetic resource banks and seed vault initiatives
• Support of longitudinal cohort studies requiring decades-long sample stability (e.g., UK Biobank, All of Us)
• On-site LN₂ buffering for flow cytometry core labs and single-cell genomics facilities

FAQ

What is the difference between vapor-phase and liquid-phase storage in the CryoMizer?
Vapor-phase storage maintains samples above the LN₂ meniscus at −135 °C, reducing contamination risk from shared liquid baths. Liquid-phase storage immerses vials directly in LN₂ at −196 °C, delivering maximum thermal stability for highly sensitive cell types.
Are the evaporation rates listed in the datasheet guaranteed?
No. Published evaporation rates (e.g., 0.39 L/day for CM-1) reflect nominal performance under controlled ISO 17025-calibrated ambient conditions (22 °C, 50% RH, no door cycling). Actual rates vary with ambient temperature, humidity, frequency of lid opening, and rack loading density.
Can the CryoMizer be validated for IQ/OQ/PQ protocols?
Yes. The tank’s mechanical repeatability, thermal mapping capability (using Class A Pt100 probes), and configurable accessory interfaces support full qualification per ASTM F2656-22 and ISO/IEC 17025 requirements.
Is remote monitoring supported out of the box?
Not natively—but the optional LN₂ level transmitter (model LT-200) provides analog/digital outputs compatible with most industrial SCADA and LIMS platforms.
Do Cryosafe tanks meet UN 2037 transport regulations?
No. The CryoMizer is designed exclusively for stationary laboratory use. Transport requires dedicated UN-certified portable dewars compliant with IMDG Code and 49 CFR 173.319.